Jean Jacques Vanden Eynde

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 11

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Université de Mons

Université de Mons (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Mons Oct 01 2009 - Oct 30 2013

Belgium

Head :: Organic Chemistry

Education History

Université de Mons

Belgium

PHD :: organic chemistry

Publications

Jean Jacques Vanden Eynde
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes? Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Jean Jacques Vanden Eynde
COVID-19: An Update About the Discovery Clinical Trial. Pharmaceuticals (Basel, Switzerland) 13 (5) (2020)
Jean Jacques Vanden Eynde
2019: An Awesome Year for Pharmaceuticals. Pharmaceuticals (Basel, Switzerland) 13 (1) (2020)
Jean Jacques Vanden Eynde, Arduino Aleksander Mangoni, Jarkko Rautio, Jérôme Leprince, Yasu-Taka Azuma, Alfonso T García-Sosa, Christopher Hulme, Josef Jampilek, Rafik Karaman, Wei Li, Paula A C Gomes, Dimitra Hadjipavlou-Litina, Raffaele Capasso, Athina Geronikaki, Gennaro Chiappetta, Jean Marc Sabatier, Rino Ragno, Tiziano Tuccinardi, Andrea Trabocchi, Jean-Yves Winum, Francisco Javier Luque, Katalin Prokai-Tatrai, Mariana Spetea, Michael Gütschow, Ivan Kosalec, Catherine Guillou, Maria Helena Vasconcelos, George Kokotos, Giulio Rastelli, Maria Emília Sousa, Clementina Manera, Sandra Gemma, Stefano Mangani, Carlo Siciliano, Stefania Galdieroa, Hong Liu, Peter J H Scott, Cristóbal de Los Ríos, Luigi A Agrofoglio, Simona Collina, Rita C Guedes, Diego Muñoz-Torrero
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6. Molecules (Basel, Switzerland) 25 (1) (2019)
Annie Mayence, Jean Jacques Vanden Eynde
Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria. Pharmaceuticals (Basel, Switzerland) 12 (3) (2019)
Arduino Aleksander Mangoni, Jean Jacques Vanden Eynde, Josef Jampilek, Dimitra Hadjipavlou-Litina, Hong Liu, Jóhannes Reynisson, Maria Emília Sousa, Paula A C Gomes, Katalin Prokai-Tatrai, Tiziano Tuccinardi, Jean Marc Sabatier, Francisco Javier Luque, Jarkko Rautio, Rafik Karaman, Maria Helena Vasconcelos, Sandra Gemma, Stefania Galdieroa, Christopher Hulme, Simona Collina, Michael Gütschow, George Kokotos, Carlo Siciliano, Raffaele Capasso, Luigi A Agrofoglio, Rino Ragno, Diego Muñoz-Torrero
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-5. Molecules (Basel, Switzerland) 24 (13) (2019)
Annie Mayence, Jean Jacques Vanden Eynde
Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases. Pharmaceuticals (Basel, Switzerland) 12 (1) (2019)
Annie Mayence, Jean Jacques Vanden Eynde
Third International Electronic Conference on Medicinal Chemistry (ECMC-3). Pharmaceuticals (Basel, Switzerland) 11 (1) (2018)
Arduino Aleksander Mangoni, Tiziano Tuccinardi, Simona Collina, Jean Jacques Vanden Eynde, Diego Muñoz-Torrero, Rafik Karaman, Carlo Siciliano, Maria Emília Sousa, Katalin Prokai-Tatrai, Jarkko Rautio, Catherine Guillou, Michael Gütschow, Stefania Galdieroa, Hong Liu, Luigi A Agrofoglio, Jean Marc Sabatier, Christopher Hulme, George Kokotos, Qi-Dong You, Paula A C Gomes
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3. Molecules (Basel, Switzerland) 23 (7) (2018)
Arduino Aleksander Mangoni, Catherine Guillou, Jean Jacques Vanden Eynde, Christopher Hulme, Josef Jampilek, Wei Li, Katalin Prokai-Tatrai, Jarkko Rautio, Simona Collina, Tiziano Tuccinardi, Maria Emília Sousa, Jean Marc Sabatier, Stefania Galdieroa, Rafik Karaman, George Kokotos, Giangiacomo Torri, Francisco Javier Luque, Maria Helena Vasconcelos, Dimitra Hadjipavlou-Litina, Carlo Siciliano, Michael Gütschow, Rino Ragno, Paula A C Gomes, Luigi A Agrofoglio, Diego Muñoz-Torrero
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes⁻4. Molecules (Basel, Switzerland) 24 (1) (2018)
Jean Jacques Vanden Eynde
2017: A Fruitful Year for Pharmaceuticals. Pharmaceuticals (Basel, Switzerland) 11 (1) (2017)

Jean Jacques Vanden Eynde.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jean Jacques Vanden Eynde